Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial of Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma (COMPLEMENT Study)

NCT06772740 is registered in ClinicalTrials.gov with Kazutaka Uchida as lead sponsor.

NCT NCT06772740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06772740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial of Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma (COMPLEMENT Study)
Lead sponsor
Kazutaka Uchida
Phase
Not applicable
Overall status
Recruiting
Start date
December 23, 2024
Completion date
March 31, 2029
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma, endovascular treatment